Voyager Therapeutics
VYGR
VYGR
52 hedge funds and large institutions have $98.1M invested in Voyager Therapeutics in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $146M → $98.1M (-$48.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $45K
Holders
52
Holding in Top 10
–
Calls
–
Puts
$45K
Top Buyers
| 1 | +$2.15M | |
| 2 | +$1.2M | |
| 3 | +$1.19M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$816K |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$627K |
Top Sellers
| 1 | -$5.76M | |
| 2 | -$3.02M | |
| 3 | -$2.16M | |
| 4 |
PIM
Partner Investment Management
San Francisco,
California
|
-$159K |
| 5 |
Morgan Stanley
New York
|
-$97.1K |